Immune-Checkpoint Inhibitors in Platinum-Resistant Ovarian Cancer

SIMPLE SUMMARY: Patients with platinum-resistant ovarian cancer experience poor prognosis. No mature evidence supports the routine adoption of immunotherapy alone in this setting. However, the combination of immunotherapy with target therapies seems to be a promising option in patients with ovarian...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Cancers (Basel)
Главные авторы: Indini, Alice, Nigro, Olga, Lengyel, Csongor György, Ghidini, Michele, Petrillo, Angelica, Lopez, Salvatore, Raspagliesi, Francesco, Trapani, Dario, Khakoo, Shelize, Bogani, Giorgio
Формат: Artigo
Язык:Inglês
Опубликовано: MDPI 2021
Предметы:
Review
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8037571/
https://ncbi.nlm.nih.gov/pubmed/33916221
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13071663
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы